Story thread · 4 reports / 4 sources
Micro-dosing Ozempic: Health optimisation or a risky gamble?
afr.com · 1d
How the coverage leans
Leans rightCoverage lean: Leans right. 0 left, 3 center, 1 right.
Across 4 sources · syndicated copies counted once
GLP-1 drugs like Wegovy and Mounjaro are approved treatments for weight loss. But not all patients who benefit from them are overweight.
First report: From ‘Ozempic breath’ to hair loss: sorting the science from the hype about weight loss jabs — theguardian.com, 3d
The coverage
- Ozempic and Wegovy may raise hair loss risk in some men
sciencedaily.com · 2d
- Video: Far-Left Authors Declare War on 'Fascist' Ozempic and Other GLP-1 Weight Loss Drugs
breitbart.com · 2d
Leans rightThis article: leans right.
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.